相关实验视频
Updated: Jan 11, 2026

07:08
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
8.3K
错误纠正测序技术的应用用于体内调节性致变性评估
Carole L Yauk1, Anthony M Lynch2, Vasily N Dobrovolsky3
1Department of Biology, University of Ottawa, Ottawa, ON, Canada.
Regulatory toxicology and pharmacology : RTP
|November 10, 2025
概括
错误纠正测序 (ECS) 提供了敏感的体内致变性评估,克服了传统方法的局限性. 专家建议支持将其纳入监管指南,以便更广泛地应用.
科学领域:
- 基因毒性测试是指基因毒性测试.
- 分子毒理学分子毒理学
- 监管科学是一种监管科学.
背景情况:
- 转基因动物 (TGR) 试验在标准毒性研究和与3R原则一致方面存在局限性.
- 错误纠正测序 (ECS) 为体内致变性评估提供了一种敏感的方法.
- 监管的接受需要达成共识,并与国际准则保持一致.
研究的目的:
- 审查错误纠正测序 (ECS) 技术用于体内致变性评估.
- 为ECS纳入经济合作与发展组织 (OECD) 测试指南制定建议.
- 支持监管机构接受ECS用于基因毒性测试.
主要方法:
- 专家工作组对国际遗传毒性测试研讨会 (IWGT) 进行了ECS技术的审查.
- 评估ECS与经过验证的转基因动物试验的一致性.
- 评估ECS在标准重复剂量毒性研究中的整合.
主要成果:
- 经过验证的转基因动物试验,ECS产生了与验证的转基因动物试验一致的结果.
- 可以将ECS纳入标准≥28天重复剂量毒性研究.
- 数据的解释应侧重于相对于并发车辆控制的突变频率.
结论:
- 对于目前的突变致病性测试来说,ECS是一个显著的进步,可以使用多样化的模型.
- 强调与经合组织原则一致的统一数据报告.
- 工作组完全支持ECS提交监管文件,并建议将其纳入未来的经合组织测试指南.
相关概念视频
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K

